Skip to main content

Table 1 Participant characteristics of the FACEHBI cohort at baselinea

From: Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline

Characteristic

Aβ-PET(−)b

Aβ-PET(+)b

P value

Participants, No. (%)

164 (82)

36 (18)

 

Age, years

66.0 (60.0-69.5)

70.0 (67.0–73.0)

.0003

Female, No. (%)

110 (67)

16 (44)

.0185

APOE ɛ4, No. (%)

 0 alleles

131 (80)

17 (47)

.0002

 1 allele

29 (18)

18 (50)

 2 alleles

4 (2)

1 (3)

Duration of education, years

15.0 (12.0–18.0)

16.0 (10.0–18.0)

.9796

FBB-PET, CL

−3.7 (−7.9–1.7)

34.1 (20.3–57.0)

< .0001

MMSE, score

29 (29–30)

30 (29–30)

.1321

S-FNAME, score

33.5 (22.0–46.0)

24.0 (16.0–33.0)

.0013

SFN-N composite, score

−0.03 (−0.61–0.65)

−0.88 (−1.05 to −0.22)

< .0001

Ventricular volumec,d, mm3

24959.5 (19776.4–32028.2)

29061.4 (21966.7–38034.6)

.1079

Hippocampal volumec,d, mm3

3606.1 (3421.0–3820.8)

3581.8 (3284.2–3792.7)

.3611

Plasma Aβ40e, pg/ml

269.3 (243.9–294.2)

297.0 (267.2–317.6)

.0009

Plasma Aβ42e, pg/ml

70.2 (63.1–77.3)

63.4 (57.8–72.1)

.0041

Plasma Aβ42/Aβ40, ratio

0.261 (0.244–0.279)

0.215 (0.203–0.236)

< .0001

  1. Abbreviations: APOE apolipoprotein E, CL centiloid, FBB-PET 18F-Florbetaben-PET, MMSE Mini-Mental State Examination, S-FNAME Spanish version of the Face-Name Associative Memory Exam, SFN-N S-FNAME-Name
  2. P values in bold correspond to statistically significant results
  3. a Data are median values (interquartile range), except for the variables participants, female and APOE ɛ4 number of alleles which are the number of cases (%). Differences between Aβ-PET(−) and Aβ-PET(+) groups were tested using Mann-Whitney and Chi-square tests, as appropriate
  4. b Aβ-PET status was defined using the cutoff established at 13.5 CL corresponding to early amyloid deposition [16]
  5. c N=198, data from two participants were lost due to MRI acquisition problems
  6. d Data correspond to regional volume corrected by total intracranial volume
  7. e Full-length intact Aβ1-40 and Aβ1-42 were quantified by ABtest-MS